Tekla Capital Management’s Impax Laboratories, Inc. IPXL Stock Holding History

Tekla Capital Management’s Portfolio IPXL Stock Details IPXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-124,335	Closed	-$2.07M	–	195
2017 Q4	$2.07M	Hold	124,335	–	–	0.08%	126
2017 Q3	$2.52M	Hold	124,335	–	–	0.09%	110
2017 Q2	$2M	Hold	124,335	–	–	0.07%	110
2017 Q1	$1.57M	Hold	124,335	–	–	0.06%	116
2016 Q4	$1.65M	Hold	124,335	–	–	0.07%	113
2016 Q3	$2.95M	Hold	124,335	–	–	0.11%	104
2016 Q2	$3.58M	Hold	124,335	–	–	0.15%	108
2016 Q1	$3.98M	Sell	124,335 -220,348	-64%	-$7.75M	0.17%	97
2015 Q4	$14.7M	Hold	344,683	–	–	0.53%	38
2015 Q3	$12.1M	Hold	344,683	–	–	0.44%	46
2015 Q2	$15.8M	Hold	344,683	–	–	0.57%	36
2015 Q1	$16.2M	Hold	344,683	–	–	0.64%	39
2014 Q4	$10.9M	Sell	344,683 -645,600	-65%	-$18.9M	0.51%	46
2014 Q3	$23.5M	Buy	990,283 +645,600	+187%	+$16.5M	1.1%	25
2014 Q2	$10.3M	Hold	344,683	–	–	0.95%	30
2014 Q1	$9.11M	Hold	344,683	–	–	0.91%	31
2013 Q4	$8.66M	Hold	344,683	–	–	0.91%	29
2013 Q3	$7.07M	Hold	344,683	–	–	0.79%	33
2013 Q2	$6.88M	Buy	+344,683	New	+$6.12M	0.94%	32

Other funds holding IPXL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

TCW Group Los Angeles, California $13.3B AUM 34.44% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Tekla Capital Management's IPXL Position: Q1 2018 in Review

Tekla Capital Management sold out of Impax Laboratories, Inc. (IPXL) in Q1 2018, closing a stake of 124,335 shares — an estimated $2.07M sold.

Tekla Capital Management first reported a position in IPXL in Q2 2013 and held it in 19 quarters. The position peaked at $23.5M in Q3 2014. 188 funds tracked by Wall St. Rank hold IPXL as of Q1 2018.

Tekla Capital Management reported no remaining Impax Laboratories, Inc. position as of Q1 2018 after selling out during the quarter.
Tekla Capital Management sold 124,335 Impax Laboratories, Inc. shares in Q1 2018, an estimated $2.07M.
Tekla Capital Management first reported a position in Impax Laboratories, Inc. in Q2 2013 and held it in 19 quarters.
Tekla Capital Management's Impax Laboratories, Inc. position peaked at $23.5M in Q3 2014.
188 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q1 2018.

Based on Tekla Capital Management's 13F filing for Q1 2018, filed 14 May 2018.